Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
Title:
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
Author:
Marks Jr, William J Ostrem, Jill L Verhagen, Leonard Starr, Philip A Larson, Paul S Bakay, Roy AE Taylor, Robin Cahn-Weiner, Deborah A Stoessl, A Jon Olanow, C Warren Bartus, Raymond T